ontilyv
bial portela & companhia s.a. - opicapone - choroba parkinsona - leki przeciw chorobie parkinsona - ontilyv is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.
bilaflex 20 mg tabletki
biofarm sp. z o.o. - bilastinum - tabletki - 20 mg
silderos max 50 mg tabletki powlekane
synoptis pharma sp. z o.o. - sildenafil citrate - tabletki powlekane - 50 mg
sildenafil synoptis 100 mg tabletki powlekane
synoptis pharma sp. z o.o. - sildenafil citrate - tabletki powlekane - 100 mg
silderos 25 mg tabletki powlekane
synoptis pharma sp. z o.o. - sildenafil citrate - tabletki powlekane - 25 mg
uplizna
horizon therapeutics ireland dac - inebilizumab - neuromyelitis optica - leki immunosupresyjne - uplizna is indicated as monotherapy for the treatment of adult patients with neuromyelitis optica spectrum disorders (nmosd) who are anti-aquaporin 4 immunoglobulin g (aqp4-igg) seropositive (see section 5.
bilastyna hitaxa 20 mg tabletki
adamed pharma s.a. - bilastyna - tabletki - 20 mg
permen med forte 50 mg tabletki powlekane
walmark a.s. - sildenafilum - tabletki powlekane - 50 mg
sildenafil walmark 100 mg tabletki powlekane
walmark a.s. - sildenafilum - tabletki powlekane - 100 mg
kinpeygo
stada arzneimittel ag - budesonide, micronised - glomerulonephritis, iga - przeciw rozwolnieniem, patogenów jelitowych przeciwzapalne / antiinfective - kinpeygo is indicated for the treatment of primary immunoglobulin a (iga) nephropathy (igan) in adults at risk of rapid disease progression with a urine protein-to-creatinine ratio (upcr) ≥1. 5 g/gram.